Roberts v. the Future: Genetic Screening and the Future of Personal Autonomy
By New York Times,
New York Times
| 08. 28. 2005
III. Genetic Screening and the Future of Personal Autonomy
Every Supreme Court confirmation hearing since the election of Ronald Reagan has been marked by efforts -- nearly always unsuccessful -- to predict the nominee's views on Roe v. Wade. The Roberts hearings are unlikely to prove an exception. If Roberts is confirmed, he will have two opportunities in the next Supreme Court term to reveal some of his views about the potential implications of Roe -- in one case involving a teen-health exception in parental-notification laws and in another concerning the federal power to prosecute protesters at abortion clinics. Regardless of whether Roe v. Wade remains on the books in 10 or 20 years, however, America's political and legal disputes about reproduction may well have moved far beyond efforts to balance the interests of a fetus against the interests of a pregnant mother. Instead, the country will most likely be debating the use of sophisticated technologies involving genetic manipulation and reproductive cloning outside the womb -- controversial procedures that may prompt restrictions or bans by state legislatures or Congress. In...
Related Articles
By Abby Vesoulis, Mother Jones | 04.18.2026
Two years ago, we devoted an entire issue to the rise of the American oligarchy. Since then, our oligarchic system has become more entrenched and pervasive, revolving around a small crew of tech titans whose quest for wealth and...
By Peter Ward, Slate | 03.30.2026
I’m in a cramped examination room at a clinic in Panama City. The lights are dim, and calming classical music plays from built-in speakers. A nurse has injected a dose of stem cells into Kenneth Scott through an IV in...
By Fyodor D. Urnov and Sadik H. Kassim, Nature | 04.21.2026
In February, the US Food and Drug Administration (FDA) proposed a radical rethink of how scientists, physicians and manufacturers develop personalized genetic therapies. The regulator’s suggested introduction of a ‘plausible mechanism pathway’ should increase incentives for drug companies to develop...
By Carly Mallenbaum, Axios [cites Emily Galpern] | 03.29.2026
More Americans are turning to surrogacy to build their families, as the practice becomes more common and more publicly discussed.
Why it matters: As surrogacy becomes more visible and accessible, ethical, legal and cultural tensions become harder to ignore...